Millennium Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $5.21M | Buy |
|
|||||
|
2024
Q4 | $829K | Sell |
|
|||||
|
2024
Q3 | $1.64M | Buy |
|
|||||
|
2024
Q2 | $372K | Buy |
|
|||||
|
2024
Q1 | $41.4K | Sell |
|
|||||
|
2023
Q4 | $71.9K | Sell |
|
|||||
|
2023
Q3 | $158K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.85M | Buy |
|
|||||
|
2022
Q4 | $1.61M | Sell |
|
|||||
|
2022
Q3 | $1.85M | Sell |
|
|||||
|
2022
Q2 | $2.66M | Sell |
|
|||||
|
2022
Q1 | $4.47M | Sell |
|
|||||
|
2021
Q4 | $7.04M | Buy |
|
|||||
|
2021
Q3 | $2.85M | Buy |
|
|||||
|
2021
Q2 | $351K | Buy |
|
|||||
|
2021
Q1 | $305K | Sell |
|
|||||
|
2020
Q4 | $433K | Sell |
|
|||||
|
2020
Q3 | $1.53K | Sell |
|
|||||
|
2020
Q2 | $3.24M | Buy |
|
|||||
|
2020
Q1 | $2.18M | Buy |
|
|||||
|
2019
Q4 | $4.35M | Sell |
|
|||||
|
2019
Q3 | $2.87M | Buy |
|
|||||
|
2019
Q2 | $280K | Buy |
|
|||||
|
2019
Q1 | $76K | Sell |
|
|||||
|
2018
Q4 | $221K | Buy |
|
|||||
|
2018
Q3 | $321K | Sell |
|
|||||
|
2018
Q2 | $3.79M | Sell |
|
|||||
|
2018
Q1 | $6.98M | Buy |
|
|||||
|
2017
Q4 | $611K | Buy |
|
|||||
|
2017
Q3 | $335K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $475K | Sell |
|
|||||
|
2016
Q4 | $842K | Sell |
|
|||||
|
2016
Q3 | $1.81M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $590K | Buy |
|